Last A$0.87 AUD
Change Today -0.01 / -1.14%
Volume 737.0K
As of 11:37 PM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).

australian pharma indus ltd (API) Snapshot

Open
A$0.88
Previous Close
A$0.88
Day High
A$0.90
Day Low
A$0.86
52 Week High
12/18/14 - A$0.98
52 Week Low
04/17/14 - A$0.49
Market Cap
422.2M
Average Volume 10 Days
827.4K
EPS TTM
A$-0.19
Shares Outstanding
488.1M
EX-Date
11/12/14
P/E TM
--
Dividend
A$0.05
Dividend Yield
5.78%
Current Stock Chart for AUSTRALIAN PHARMA INDUS LTD (API)

Related News

No related news articles were found.

australian pharma indus ltd (API) Related Businessweek News

No Related Businessweek News Found

australian pharma indus ltd (API) Details

Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical and associated products to pharmacies in Australia. The company operates in three segments: Pharmacy Distribution, Retailing, and Manufacturing. It also provides finance origination and retail services to pharmacists under the Soul Pattinson and Pharmacist Advice banners, as well as offers product delivery, marketing programs, and business advisory services. In addition, the company purchases and sells health, beauty, and lifestyle products in the retail industry under the Priceline brand, as well as operates as a franchisor with approximately 150 Priceline Pharmacy stores. Further, it manufactures and owns rights of pharmaceutical medicines and consumer toiletries in New Zealand. The company was founded in 1910 and is based in Camellia, Australia.

Founded in 1910

australian pharma indus ltd (API) Top Compensated Officers

Chief Executive Officer, Managing Director an...
Total Annual Compensation: A$910.7K
Group General Manager of Business Development...
Total Annual Compensation: A$604.7K
Chief Legal Counsel and Company Secretary
Total Annual Compensation: A$397.8K
Group General Manager of People
Total Annual Compensation: A$371.6K
Compensation as of Fiscal Year 2014.

australian pharma indus ltd (API) Key Developments

Mr. Graeme Fallet to Leave Australian Pharmaceutical Industries Limited as Chief Financial Officer Effective 19 December 2014

Australian Pharmaceutical Industries Limited announced that Mr. Graeme Fallet, Chief Financial Officer, will be leaving the company effective 19 December 2014 to pursue other interests.

Australian Pharmaceutical Industries Limited Declares Dividend for the Full Year of 2014

Australian Pharmaceutical Industries Limited declared dividend for the full year of 2014. The strong underlying performance of the company meant that the total dividend payment for the year of 2014, of 3.5 cents per share, was up 7.7% on the prior year.

Australian Pharmaceutical Industries Limited Reports Audited Consolidated Earnings Results for the Year Ended August 31, 2014

Australian Pharmaceutical Industries Limited reported audited consolidated earnings results for the year ended August 31, 2014. For the period, the company reported revenue of AUD 3,345.946 million against AUD 3,166.369 million a year ago. Loss from operating activities was AUD 45.868 million against result from operating activities of AUD 55.908 million a year ago. Loss before tax was AUD 85.044 million against profit before tax of AUD 35.028 million a year ago. Loss profit for the period attributable to equity holders of the company was AUD 90.771 million or 18.6 cents per basic and diluted share against profit for the period attributable to equity holders of the company of AUD 24.292 million or 5.0 cents per basic and diluted share a year ago. Net cash from operating activities was AUD 64.188 million against AUD 66.600 million a year ago. Acquisition of property, plant and equipment was AUD 10.863 million against AUD 18.875 million a year ago. Payment for intangibles was AUD 19.263 million against AUD 6.223 million a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
API:AU A$0.87 AUD -0.01

API Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for API.
View Industry Companies
 

Industry Analysis

API

Industry Average

Valuation API Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.1x
Price/Book 0.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AUSTRALIAN PHARMA INDUS LTD, please visit www.api.net.au. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.